Table 2 Healthcare costs of breast cancer in the Netherlands in Million Euro’s
From: Burden of early, advanced and metastatic breast cancer in The Netherlands
Expenditure | 2003 | 2005 | 2007 | 2011 | Estimates 2014 |
|---|---|---|---|---|---|
Public healthcare and prevention | 41.8 (21%) | 44 (18%) | 47.7 (11%) | 63.1 (9%) | 9% |
1st line care | 4.6 (2%) | 5.1 (2%) | 7.1 (2%) | 7.5 (1%) | 1% |
Hospital & medical professional care | 96.5 (49%) | 129.8 (54%) | 280.7 (65%) | 542.6 (78%) | 78% |
Elderly Care | 19.3 (10%) | 18.5 (8%) | 19.1 (4%) | 17.8 (3%) | 3% |
Drugs | 26.7 (13%) | 32.6 (13%) | 57.1 (13%) | 45.7 (7%) | 7% |
Other healthcare providers | 3.1 (2%) | 3.3 (1%) | 5.7 (1%) | 2.7 (0%) | 0% |
Management | 6.7 (3%) | 8.9 (4%) | 12.2 (3%) | 12.5 (2%) | 2% |
Total Costs in Million (€) | 199 (0.31%a) | 243 (0.36%a) | 430 (0.58%a) | 696 (0.78%a) | 768 (0.80%a) |